[ad_1]
Medical sources have speculated that two new drugs, the first of their kind designed to prevent migraines, will soon be introduced after the European Medicines Agency has approved them.
Health workers in England and Scotland study the two commercially known medicines, Erinumab and Imovig, according to Sky News.
Novartis said that patients can access the drug at their expense starting in September, although it is not offered by the FDA. Health Services
The drug acts to prevent receptors in the blood called peptide receptors, which are believed to contribute to the attack of migraine, although scientists are not sure of the main cause of headaches the more severe.
The European Medicines Agency approved the drug for migraine patients four times
The patient will take the drug at home with a pen injector.
The trial showed that the drug halved the number of migraine days in a month.
[ad_2]
Source link
